Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

Clinical trial NCT01686945 · COMPLETED

Trial details

NCT number

NCT01686945

Sponsor

Novo Nordisk A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2012-09-19

Primary completion

2013-04-08

Enrollment

107

View on ClinicalTrials.gov